Letter to the EditorActivity of RX-P873, a novel pyrrolocytosine, against Gram-negative bacteria☆
Section snippets
Funding
IHMA Europe received funding from Melinta Therapeutics for the experimental work and writing of this manuscript.
Competing interests
IM, SM, EG, PJ and SH are employees of IHMA Europe; AM and ED are employees of Melinta Therapeutics.
Ethical approval
Not required.
References (5)
- et al.
Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials
Expert Opin Pharmacother
(2015) - US. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013....
There are more references available in the full text version of this article.
Cited by (0)
- ☆
These data were presented in part at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5–9 September 2014, Washington, DC [abstract C-1373].
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.